Journal Homepage Image

Osteoporosis and Bone Diseases


Since 1998 the “Osteoporosis and Bone Diseases” (also issues with transliterated titles “Osteoporoz i osteopatii” and "Osteoporosis and Osteopathy") journal has been publishing timely articles, balancing both clinical and experimental research, case reports, reviews and lectures on pressing problems of bone disorders and mineral metabolism.

The Journal pays special attention to the most relevant issues of bone tissue mineral metabolism disturbances, its etiology, pathogenesis, clinical findings and pharmacotherapy.

The Journal:

  • features original national and foreign research articles, reflecting world endocrinology end reumatology development;
  • issues thematic editions on specific areas;
  • publishes chronicle of major international congress sessions and workshops on osteoporosis and osteopathies, as well as state-of-the-art guidelines;
  • is intended for scientists, endocrinologists, rheumatologists, traumatologists, gerontologists and specialists of allied trade, general practitioners and family physicians.


Liudmila Ya. Rozhinskaya, MD, PhD, Professor (ORCID: 0000-0001-7041-0732)


The journal is is currently indexed in Russian Science Citation Index (RSCI) by “Electronic Scientific Library” foundation (, DOAJGoogle ScholarSocionetUlrich's Periodicals DirectoryWorldCat.

Access to the content

All accepted articles in Osteoporosis and Bone Diseases journal are published in Gold Open Access (in accordance with Budapest Open Access Initiative) format with Free Full-text access to all articles via several websites ( and mobile applications for iOS® (available in AppStore). All accepted articles publish with the Creative Commons International license (CC BY-NC-ND 4.0) for more freely distribution and usage worlwide.

The journal is open for English and Russian language manuscripts. All English language manuscripts are published in bilingual format (with help of Russian association of endocrinologists and the Russian association for osteoporosis the editorial team makes translations for all accepted english-language articles). So, the journal provide an additional readers auditory for published articles. 



What are the treatment options and optimal timing for post-fracture care?


The Amgen-sponsored symposium at the FFN (Fragility Fracture Network) 2017 Congress provided an interactive educational opportunity for delegates, and was led by Mattias Lorentzon (Sweden) as meeting chair. He was joined by Bente Langdahl (Denmark) who presented on the treatment options and optimal timing for post-fracture care

Posted: 04.04.2018 More...

Report on the Presidium of the Russian Association for Osteoporosis


On February 3, 2018, the planned meeting of the presidium of the Russian Association for Osteoporosis (RAOP) was held.

Posted: 04.04.2018 More...
More Announcements...

Current Issue

Vol 20, No 3 (2017)

Features of bone metabolism in diabetes mellitus
Nurullina G.M., Akhmadullina G.I.
Osteoporosis and Bone Diseases. 2017;20(3):82-89
Non-classical effects of vitamin D
Pigarova E.A., Petrushkina A.A.
Osteoporosis and Bone Diseases. 2017;20(3):90-101
Case report
Functional hypoparathyroidism secondary to magnesium deficiency in long-term users of proton pump inhibitor
Egshatyan L.V.
Osteoporosis and Bone Diseases. 2017;20(3):102-107
Role of parathyroid hormone measurement in fine-needle aspiration biopsy washout in diagnosis and treatment of primary hyperparathyroidism
Beltsevich D.G., Voskoboynikov V.V., Klycheva C.M., Roslyakova A.A., Ladygina D.O.
Osteoporosis and Bone Diseases. 2017;20(3):108-113
Glucocorticoid-induced osteoporosis: presentation and comments on the new American College of Rheumatology guidelines
Toroptsova N.V.
Osteoporosis and Bone Diseases. 2017;20(3):114-120